Sonnet Biotherapeutics Holdings
SONN · NASDAQ
$51.02+$51.02 (+0.00%)TodayMarket closed ·
Prev close $0.00
About SONN
- Employees
- 13
- Headquarters
- Princeton, New Jersey
- Listed
- Jul 27, 2005
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- sonnetbio.com
Leadership
| Name | Title | Since |
|---|---|---|
| Raghu Rao | — | 2020 |
| Jenene Thomas | — | 2025 |
Revenue by product and region
Fiscal year ended Dec 31, 2019: $30.14M total revenue
By product
- Restaurant Sales, Net [Member]$29.06M96.4%
- Franchise Income [Member]$575.09K1.9%
- Gaming Income, Net [Member]$462.51K1.5%
- Management Fee Income [Member]$50.00K0.2%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| XOMA XOMA | Supplier and customer | 0.81 |
| Merck MRK.DE | Supplier and customer | -0.30 |
| New Life Therapeutics Pte Ltd. | Supplier and customer | — |
Similar companies
Companies in the same industry as Sonnet Biotherapeutics Holdings
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.